ABSTRACT
No disponible
Subject(s)
Female , Male , Humans , Infant, Newborn , Facial Paralysis/congenital , Genetic Counseling/methods , Misoprostol/adverse effects , Facial Paralysis/congenital , Chromosomes, Human, Pair 13/genetics , Deglutition Disorders/genetics , Strabismus/genetics , Talipes/genetics , Poland Syndrome/genetics , Chromosome Aberrations/genetics , Intellectual Disability/geneticsABSTRACT
BACKGROUND: Vertical banded gastroplasty (VBG) has been found to result in significant reduction in body mass index (BMI) during the first postoperative year. We investigated the impact of some intrinsic and extrinsic factors on long-term BMI evolution in morbidly obese patients who underwent VBG, with the aim of establishing a long-term weight-loss prognosis. METHODS: 67 consecutive morbidly obese patients who underwent VBG were followed for 2 years; of these, 34 were followed 3 more years, for a total follow-up of 5 years. BMI was monitored and correlated with demographic (preoperative BMI, obese relatives, age and gender) and lifestyle variables (physical activity, habitual dietary transgression and occupational status). RESULTS: Global BMI fell from 47.5 at the time of the intervention to 32.1 when patients were examined 12 months after surgery. From the second year, an upward trend was observed, and at 5 years, mean BMI was above 35, considered in the high-risk range. Modifiable variables affecting lifestyle have shown significantly favorable effects on BMI evolution. Among intrinsic variables, BMI before surgery and obese parents also affect long-term evolution. CONCLUSION: Different variables should be considered in order to establish a long-term weight-loss prognosis for each patient, thus making it possible to act more specifically on modifiable variables.
Subject(s)
Body Mass Index , Gastroplasty/methods , Obesity, Morbid/surgery , Adult , Female , Follow-Up Studies , Humans , Life Style , Male , Middle Aged , Weight Gain , Weight Loss/physiologyABSTRACT
Based on genetic variability, structural differences in the glycoprotein IIb/IIIa platelet receptor for adhesive proteins result in individual differences in the thrombogenicity of platelets. Recent studies suggest a controversial association between a genetic polymorphism of the glycoprotein IIIa gene (PlA2) and the risk of coronary artery disease. In our study, the prevalence of the PlA2 allele in a group of patients undergoing percutaneous coronary revascularization was 37%, a value significantly higher than in controls [13%, odds ratio (OR) = 3.93, 95% CI, 1.84 to 8.53] suggesting a significant association between this polymorphism and documented coronary stenosis, which is strongest among <60 years old patients (OR = 12.30, 95% CI, 2.98 to 70.93). This polymorphism represents an inherited risk factor for severe cardiovascular disease due to coronary occlusion.
Subject(s)
Coronary Disease/genetics , Platelet Glycoprotein GPIIb-IIIa Complex/genetics , Polymorphism, Genetic , Aged , Alcohol Drinking/epidemiology , Alleles , Angioplasty, Balloon, Coronary , Combined Modality Therapy , Comorbidity , Coronary Disease/epidemiology , Coronary Disease/surgery , Coronary Disease/therapy , Diabetes Mellitus/epidemiology , Female , Fibrinogen/analysis , Gene Frequency , Genotype , Humans , Hypertension/epidemiology , Lipids/blood , Male , Middle Aged , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , Prevalence , Risk Factors , Smoking/epidemiology , StentsABSTRACT
Throughout the last few decades, different factors have been related to coronary stenosis which is clinically evidenced by coronary heart disease, the leading cause of death in developed countries. Different experimental models have contributed towards defining some of these factors, and to an understanding of the physiopathology of the atherosclerotic lesion. The genetic basis related to individual responses to the same event is currently being established. As endothelial injury reparative mechanisms are fundamental in atherosclerosis pathogeny, patients who experiment restenosis after undergoing revascularization procedures are useful human models in the study of these processes. We review from the literature the genetic factors related to thrombus formation, which may be associated with restenosis after percutaneous transluminal coronary angioplasty, in order to define the most suitable anticoagulant therapy for each patient. We refer to the recently characterized gene for the platelet receptors and its relationship with fibrinogenous, factor Xa, PAI-I, and the involvement of apolipoprotein (a) in the coagulation process.
